Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer
Clinical trial NCT00793377 · COMPLETED
Trial details
- NCT number
- NCT00793377
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 913
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.